Jiangtong Peng
Overview
Explore the profile of Jiangtong Peng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
472
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lin J, Peng J, Lv B, Cao Z, Chen Z
Front Cardiovasc Med
. 2024 Jun;
11:1374241.
PMID: 38841257
Hereditary transthyretin amyloid (ATTRv) cardiomyopathy (CM) is caused by mutations in the TTR gene. TTR mutations contribute to TTR tetramer destabilization and dissociation, leading to excessive deposition of insoluble amyloid...
2.
Liu K, Yang L, Wang P, Zhu J, Li F, Peng J, et al.
Inflammopharmacology
. 2024 Mar;
32(3):1887-1901.
PMID: 38526770
Sepsis, a life-threatening condition characterized by dysregulated immune responses, remains a significant clinical challenge. Myricanol, a natural compound, plays a variety of roles in regulating lipid metabolism, anti-cancer, anti-neurodegeneration, and...
3.
Miao Y, Zhong Y, Li Y, Qin H, Yang L, Cao G, et al.
Diabetes
. 2024 Mar;
73(6):909-925.
PMID: 38466834
Article Highlights:
4.
Zhu X, Peng J, Yang L, Guo Y, Wang P, Liu K, et al.
Eur J Pharmacol
. 2022 Sep;
933:175268.
PMID: 36103933
Endothelial cells (ECs) are vital regulators of inflammatory processes, there is the potential for inhibition of EC inflammation to be a therapeutic target in chronic inflammatory diseases. This study aimed...
5.
Du M, Wang C, Yang L, Liu B, Zheng Z, Yang L, et al.
iScience
. 2022 Mar;
25(3):103978.
PMID: 35295812
The major clinical consequences of atherosclerosis such as myocardial infarction or stroke are because of thrombotic events associated with acute rupture or erosion of an unstable plaque. Here, we identify...
6.
Yu Z, Luo R, Li Y, Li X, Yang Z, Peng J, et al.
J Cell Sci
. 2022 Jan;
135(5).
PMID: 35067718
Adipogenesis is closely related to various metabolic diseases, such as obesity, type 2 diabetes, cardiovascular diseases and cancer. This cellular process is highly dependent on the expression and sequential activation...
7.
Tao X, He H, Peng J, Xu R, Fu J, Hu Y, et al.
Pharmacol Res
. 2021 Nov;
175:106004.
PMID: 34826603
Emerging evidence has shown that nonalcoholic fatty liver disease (NAFLD) may be both a consequence and a cause of hypertension. Recent studies have demonstrated that phosphodiesterase 4 (PDE4)-cAMP signaling represents...
8.
Zheng Y, Huang Y, Zheng X, Peng J, Chen Y, Yu K, et al.
Aging (Albany NY)
. 2021 Apr;
13(9):12641-12659.
PMID: 33910167
Features of the deaths caused by COPD (chronic obstructive pulmonary disease) in cancer patients remained a controversial issue. This study aimed to characterize the demographic characteristics and mortality rates of...
9.
Du M, Wang X, Yuan L, Liu B, Mao X, Huang D, et al.
J Hepatol
. 2020 Jul;
73(6):1333-1346.
PMID: 32717288
Background & Aims: The nuclear factor of activated T-cells (NFAT) family was first recognised to play an important role in the differentiation of T cells, but has since been shown...
10.
Shao W, Li X, Peng J, Fan S, Liang M, Huang K
J Cell Mol Med
. 2020 Jul;
24(17):10128-10139.
PMID: 32697395
Apatinib (YN968D1) is a small-molecule tyrosine kinase inhibitor（TKI）which can inhibit the activity of vascular endothelial growth factor receptor-2 (VEGFR-2). It has been reported that apatinib has anti-tumour effect of inhibiting...